The world's top biopharmaceutical companies 'Amgen' is preparing to enter domestic pharmaceutical market in Korea
The world's top biopharmaceutical companies 'Amgen' is preparing to enter domestic pharmaceutical market in Korea.
On September 4, according to related industry, Amgen completed the adoption of the person in charge of licensing regulation (RA) through the local headhunting company recently and s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
